ArticleRecent patents on anti-cancer drug discovery2025

A Single-arm, Open-label, Phase Ib Clinical Study Evaluating the Efficacy and Safety of Durvalumab in Combination with Albumin-bound Paclitaxel and Carboplatin as Neoadjuvant Therapy for Resectable Stage III Non-small Cell Lung Cancer.

Yuejiao Zhong et al.PubMed ↗Publisher ↗

No numbers read from the abstract.